137
In the Name of God

M. Tuberculosis and immune responses

Embed Size (px)

DESCRIPTION

Updates on M Tuberculosis

Citation preview

Page 1: M. Tuberculosis and immune responses

In the Name of God

Page 2: M. Tuberculosis and immune responses

M. Tuberculosis and

immune responses

Presented By : M. Barabadi , S. Keshavarz Shahbaz

Supervised by : Dr. Noorbakhsh

Tehran university of medical science

Page 3: M. Tuberculosis and immune responses

Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB

• Experimental models• Immune response against TB

- Innate immune defense- Adaptive immune defense

• HIV and TB• Difficulties and advantages in TB research• Risk factors

Page 4: M. Tuberculosis and immune responses
Page 5: M. Tuberculosis and immune responses
Page 6: M. Tuberculosis and immune responses
Page 7: M. Tuberculosis and immune responses
Page 8: M. Tuberculosis and immune responses
Page 9: M. Tuberculosis and immune responses
Page 10: M. Tuberculosis and immune responses
Page 11: M. Tuberculosis and immune responses
Page 12: M. Tuberculosis and immune responses
Page 13: M. Tuberculosis and immune responses
Page 14: M. Tuberculosis and immune responses

Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB

• Experimental models• Immune response against TB

- Innate immune defense- Adaptive immune defense

• HIV and TB• Difficulties and advantages in TB reaserch• Risk factors

Page 15: M. Tuberculosis and immune responses
Page 16: M. Tuberculosis and immune responses
Page 17: M. Tuberculosis and immune responses

The pathogen structure:

Page 18: M. Tuberculosis and immune responses
Page 19: M. Tuberculosis and immune responses
Page 20: M. Tuberculosis and immune responses

Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB

• Experimental models• Immune response against TB

- Innate immune defense- Adaptive immune defense

• HIV and TB• Difficulties and advantages in TB reaserch• Risk factors

Page 21: M. Tuberculosis and immune responses

M. Tuberculosis Characteristics

• Slow-growing• Facultative Intracellular• Gram-positive• Non Spore Forming• Aerobic• Acid-fast bacilli

Page 22: M. Tuberculosis and immune responses
Page 23: M. Tuberculosis and immune responses

Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB

• Experimental models• Immune response against TB

- Innate immune defense- Adaptive immune defense

• HIV and TB• Difficulties and advantages in TB reaserch• Risk factors

Page 24: M. Tuberculosis and immune responses
Page 25: M. Tuberculosis and immune responses

Spine TB :

Nemhotep,Priest of Amun died about 1000 BCE

Page 26: M. Tuberculosis and immune responses

Brain TB :

Page 28: M. Tuberculosis and immune responses
Page 29: M. Tuberculosis and immune responses

Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB

• Experimental models• Immune response against TB

- Innate immune defense- Adaptive immune defense

• HIV and TB• Difficulties and advantages in TB reaserch• Risk factors

Page 30: M. Tuberculosis and immune responses

The TB Song.flv

Page 31: M. Tuberculosis and immune responses
Page 32: M. Tuberculosis and immune responses

Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB

• Experimental models• Immune response against TB

- Innate immune defense- Adaptive immune defense

• HIV and TB• Difficulties and advantages in TB reaserch• Risk factors

Page 33: M. Tuberculosis and immune responses
Page 34: M. Tuberculosis and immune responses
Page 35: M. Tuberculosis and immune responses
Page 36: M. Tuberculosis and immune responses
Page 37: M. Tuberculosis and immune responses
Page 38: M. Tuberculosis and immune responses

Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB

• Experimental models• Immune response against TB

- Innate immune defense- Adaptive immune defense

• HIV and TB• Difficulties and advantages in TB research• Risk factors

Page 39: M. Tuberculosis and immune responses

Active vs. latent TB :

Tuberculosis.flv

Page 40: M. Tuberculosis and immune responses

Active TB :

Page 41: M. Tuberculosis and immune responses

Active TB:

• Two Forms :1. Primary-progressive TB (more common in

children) :Progress rapidly to active disease

2. Post-primary TB: present after an interval of many years following exposure

Page 42: M. Tuberculosis and immune responses

Differences :

I. Clinical presentations II. Different temporal pathogenesisIII. Host genetic susceptibilities

Page 43: M. Tuberculosis and immune responses

Diagnosis :

Page 44: M. Tuberculosis and immune responses
Page 45: M. Tuberculosis and immune responses
Page 46: M. Tuberculosis and immune responses

M.TB visualization using the Ziehl–Neelsen stain :

Page 47: M. Tuberculosis and immune responses

M. TB bacterial colonies

Isolation and confirmation of TB by culture take up to 6 weeks .

Page 48: M. Tuberculosis and immune responses

• 2 months after treatment ,the culture from sputum becomes negative. It is the only accepted biomarker but with low sensitivity and modest specificity .

Page 49: M. Tuberculosis and immune responses

• Confirmation of Diagnosis is necessary Because clinical presentation of TB is nonspecific and overlaps with:

- pneumonia- lung cancer- sarcoidosis

Page 50: M. Tuberculosis and immune responses

Xpert MTB/RIF automated molecular PCR

• A cartridge-based, automated diagnostic test that can identify MTB and resistance to rifampicin.

• WHO recently endorsed this method.

• It answers in just 2 hour.

Page 51: M. Tuberculosis and immune responses

Treatment • The treatment is lengthy (a minimum of 6

months)• It requires the use of multiple drugs to prevent

the selection of drug-resistant mutants.

• It is divided into :A. initial intensive phase : to kill actively

replicating bacilliB. continuation phase : to target persisting bacilli

Page 52: M. Tuberculosis and immune responses

Blood Transcriptional profiling in Active TB:

• In This method we gain an understanding of immune response and potential factor that lead to the pathogenesis of TB

Page 53: M. Tuberculosis and immune responses

• 393-transcript signature, present in the blood of patients with active TB ,that was absent in most latent individuals and healthy controls.

• transcriptional signature of active TB is dominated by IFN-inducible signature

Page 54: M. Tuberculosis and immune responses
Page 55: M. Tuberculosis and immune responses

Detrimental role of Type1 IFN :

• patients with active TB have a prominent type I IFN–inducible gene signature in their blood that correlated with the extent of radiographic disease and diminished upon successful treatment

Page 56: M. Tuberculosis and immune responses

Active TB heatmap :

Page 57: M. Tuberculosis and immune responses

Advantage :

• Early change in the blood transcriptional signature --->2 weeks after treatment

• sputum smear ---> atfer2 months of treatment

Page 58: M. Tuberculosis and immune responses

• sarcoidosis patients have a similarity to M.TB patients :

They have significant overlap in the IFN-inducible genes that leads to similar immune mechanisms of granulomatous.

Page 59: M. Tuberculosis and immune responses
Page 60: M. Tuberculosis and immune responses

Latent TB :

Page 61: M. Tuberculosis and immune responses

Latent TB :

• Most infected individuals are asymptomatic• 5–10% of latent individuals will develop active

TB during their lifetime• individuals who are immunosuppressed,

particularly those with HIV coinfection are in Higher risk

Page 62: M. Tuberculosis and immune responses

Diagnosis :

Page 63: M. Tuberculosis and immune responses
Page 64: M. Tuberculosis and immune responses

• Tuberculin skin test (TST) is common

• TST is more frequently negative in those individuals most at risk of progression to active disease:

a) the young b) the elderlyc) immunosuppressed

Page 65: M. Tuberculosis and immune responses

False positive TST

• PPD is prepared from culture filtrate of TB• It contains over 200 antigens also found in the

attenuated BCG vaccine and in many environmental non-TB mycobacteria

Therefore TST has limited specificity

Page 66: M. Tuberculosis and immune responses

IGRAs :• More specific TB antigens :1. early secretory antigen target-6 (ESAT-6)2. culture filtrate protein- 10 (CFP-10) are absent from BCG and most non-TB is used

• Reactivity to these TB antigens is assessed in terms of production of IFN-γ by blood cells using IFN-γ release assays (IGRAs).

• IGRAs is measured by :1. ELISA 2. ELI-SPOT

Page 67: M. Tuberculosis and immune responses

Heterogeneity of latent TB :

Page 68: M. Tuberculosis and immune responses

Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB

• Experimental models• Immune response against TB

- Innate immune defense- Adaptive immune defense

• HIV and TB• Difficulties and advantages in TB research• Risk factors

Page 69: M. Tuberculosis and immune responses

Human TB and experimental animal models :

• The mouse model offers the best tools for the study of the immune response to TB

• Commonly used mouse strains, such as C57BL/6 or BALB/c mice

• Highly susceptible strain : CBA/J, DBA/2, and C3H

• Advantage:• Infected with low dose virulent TB• Disadvantage:• The granulomas are poorly organized and exclusively cellular• They lack fibrosis or hypoxia • The mice ultimately die • lacks the range of latency to active disease

Page 70: M. Tuberculosis and immune responses

cynomolgus macaque model It is the most commonly used model for studying latent TB The heterogeneous TB experimental model

Page 71: M. Tuberculosis and immune responses

Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB

• Experimental models• Immune response against TB

- Innate immune defense- Adaptive immune defense

• HIV and TB• Difficulties and advantages in TB research• Risk factors

Page 72: M. Tuberculosis and immune responses

Immune response in TB :

1. Formation of Granulomas2. Initials events3. MQ apoptosis4. Role of PMN(Neu)

Page 73: M. Tuberculosis and immune responses

Formation of Granulomas

Tuberculosis Invasion.mp4

Page 74: M. Tuberculosis and immune responses
Page 75: M. Tuberculosis and immune responses
Page 76: M. Tuberculosis and immune responses

• The classical feature of human TB granulomas:

The presence of a necrotic caseous core that is thought to be secondary to cell lysis that results in a central hypoxic environment .

Page 77: M. Tuberculosis and immune responses

Caseation necrosis :

Page 78: M. Tuberculosis and immune responses

Granuloma in active & latent TB :

• In latent TB the bacilli reside in the central hypoxic zone in a metabolically altered state

• In active TB they can replicate in peripheral oxygenated areas.

• Are they purely protective for the host or do they promote infection?

• The pathogen may be able to engineer a supportive environment in the granuloma

Page 79: M. Tuberculosis and immune responses

Granuloma classification in active TB:

1. The classical caseous granuloma :central eosinophilic debris surrounded by macrophages and a layer of lymphocytes

2. The non-necrotizing granuloma: internal core of macrophages and some neutrophils surrounded by a lymphocyte layer

3. The suppurative granuloma: central core of degenerative neutrophils surrounded by macrophages and multinucleated giant cells and an outer envelope of lymphocytes

Page 80: M. Tuberculosis and immune responses
Page 81: M. Tuberculosis and immune responses

First line of defence• Influx of phagocytic cells including :1. primarily resident alveolar MQ2. recruited neutrophils and DCs• Escape : TB prevents phagolysosomal fusion

and persist in the phagosome• Immune defense: Opsonization of the bacilli

prior to infection inhibits this blockade of phagolysosomal fusion

Page 82: M. Tuberculosis and immune responses

Role of MQ :

• Infection of MQ with M.TB can induce:1. necrotic death: allows exit from MQ and

therefore cell-to-cell spread of the bacilli

2. Apoptotic death : is associated with diminished pathogen viability and enhanced immunity

Page 83: M. Tuberculosis and immune responses

Efferocytosis

• TB –infected MQ are themselves rapidly engulfed by uninfected MQ through a process called efferocytosis , generally regarded as a constitutive housekeeping function of macrophages.

Page 84: M. Tuberculosis and immune responses
Page 85: M. Tuberculosis and immune responses

• The type of cell death is regulated by : The lipid mediators include :1. (proapoptotics): eicosanoids , prostaglandin E2

(PGE2) 2. (pronecrotic): lipoxin A4 (LXA4)

• Virulent strains of TB evade innate defense mechanisms of the host by inducing LXA4 and inhibiting PGE2 production

• They lead to MQ necrosis and inhibition of MQ apoptosis, ultimately resulting in mycobacterial spread.

Page 86: M. Tuberculosis and immune responses

Role of Neutrophils • Lung Neu facilitate activation of naive antigen-specificCD4+

Tcells during M .TB infection.• IT promote an anti–M.TB adaptive immune response by

delivering the bacilli to DCs in a form that makes DCs more effective initiators of CD4+ T cell activation.

• Neu have a protective or detrimental effect during an immune response to TB infection may be determined by:

1. The genetics of the pathogen as well as by the genetics of the host

2. The stage of TB disease3. Tissue environment4. Network of cytokines

Page 87: M. Tuberculosis and immune responses

Detrimental role of Neu : • Neutrophils are dominant producers of IL-10

in the lung .

• Depletion of neutrophils reduces the lung bacterial load while enhancing IL-6 and IL-17, but not IFN-γ, responses

Page 88: M. Tuberculosis and immune responses
Page 89: M. Tuberculosis and immune responses

Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB

• Experimental models• Immune response against TB

- Innate immune defense- Adaptive immune defense

• HIV and TB• Difficulties and advantages in TB research• Risk factors

Page 90: M. Tuberculosis and immune responses

Innate immune factors :

1. TNF2. Inflammation3. Pattern recognition receptors ,Adaptor

proteins

Page 91: M. Tuberculosis and immune responses

TNF• Role :1. Formation and maintenance of the integrity of the

granuloma 2. Boosting the intracellular killing of bacilli

• Granuloma formation could occur even in the absence of TNF signaling, but these granulomas were :

• Delayed• More necrotic • With higher bacillary numbers.

Page 92: M. Tuberculosis and immune responses

Inflammation :

1. Eicosanoids2. Matrix metalloproteinases : MMP-1 and MMP-9 : key collagenase upregulated in patients with TB and associated with increased lung pathology in transgenic mice 3. Vitamin Da pro-hormone that in kidney converts to its active form .Conversion can also occur in granulomatous tissue.

Page 93: M. Tuberculosis and immune responses

• Vit D3 has regulatory and anti-inflammatory immune effects ,therefore continues to be of potential therapeutic interest.

• Historically ,sunlight exposure and vitamin D were used as treatments for TB.

Page 94: M. Tuberculosis and immune responses

Pattern recognition receptors and Adaptor proteins :

• Pattern-recognition receptors (PRRs): 1. Toll-like receptors (TLRs)2. C-type lectin receptors (CLRs)including

dectin-1, mannose receptor, and DC-SIGN3. Nod-like receptors (NLRs)

Page 95: M. Tuberculosis and immune responses

• MyD88 and CARD9 :- master adaptors of TLR - critical for protective immunity to M.TB in mouse models

• TLR2, TLR4, and TLR9 play a role in host recognition of M.TB

Page 96: M. Tuberculosis and immune responses

Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB

• Experimental models• Immune response against TB

- Innate immune defense- Adaptive immune defense

• HIV and TB• Difficulties and advantages in TB research• Risk factors

Page 97: M. Tuberculosis and immune responses

Adaptive immune response :

1. T cells2. DC cells3. CD-1 restricted response4. B cell5. Cytokines

Page 98: M. Tuberculosis and immune responses

DC cell• DCs in lymph nodes from patients with M.TB may themselves

contain M.TB

• Depletion of CD11c+ cells in mice before intravenous infection with M.TB delays the development of CD4+ T cell responses

Page 99: M. Tuberculosis and immune responses

T cells

• The most important T cells is CD4+ T cells

• CD8+ T cells also contribute to anti-TB immunity by:1. Secreting IFNγ To Activate MQ to Control Infection 2. Secreting products that can directly kill The TB

bacilli.

• However, CD8+ T cells clearly can not compensate for a lack of CD4+ T cells.

Page 100: M. Tuberculosis and immune responses
Page 101: M. Tuberculosis and immune responses

CD1-Restricted Responses

• TB contains glycolipid Ag that are presented by The CD1 family molecules

• Glycolipid-reactive T cells play a role in an effective response to TB

• They proliferate and produce IFN-γ in response to TB glycolipids

Page 102: M. Tuberculosis and immune responses

B cells

• Follicle-like B cell have been observed in the lungs of M.TB patients and in the granulomas of infected mice

• Role :1. moderate inflammatory progression 2. modulating immune activation and

susceptibility to infection by induction of IL-10

Page 103: M. Tuberculosis and immune responses

IFNγ

• The most invariably detected cytokine at the sites of human TB infection in :

- Lung (most )- bronchoalveolar lavage (BAL) fluid- pleuritis fluid- lymph nodes

Page 104: M. Tuberculosis and immune responses

IFN-γ-Mediated Killingin MQ :

IFN-γ-inducible molecules include: • iNOS , LRG-47, an IFN inducible GTP-binding

protein

• IFN-γ is also important for endosome maturation and the induction of antimicrobial peptide

Page 105: M. Tuberculosis and immune responses
Page 106: M. Tuberculosis and immune responses

Control of Inflammation and CD4+T Cells

• various mechanisms are in place to prevent immunopathology, including:

1. Foxp3+ regulatory T cells2. IL-10 3. PD1 ( expressed by T cells from TB patients)

Page 107: M. Tuberculosis and immune responses

• PD-L1 is overly abundant in the whole blood of active TB patients

PD1 binded to PDl1---> negative signal chronic infection

PD1 deletion ---- > increase of M.TB-specific CD4+ T cell --- > active TB

• This finding demonstrated the importance of a finely regulated immune response to control disease.

Page 108: M. Tuberculosis and immune responses

IL-17 :

• Both IFN-γ and IL-17-producing T cells are induced during mycobacterial infection

• IFN-γ serves to limit the IL-17-producing T cell population

• IL-17 can also be produced by γδ T cells and a non-CD4+ CD8+ population .

• Role :- Granuloma formation- Th1 enhancement

Page 109: M. Tuberculosis and immune responses

Following BCG vaccination with a mycobacterial peptide:

IL-17 is required for the accelerated recruitment of IFN-γ-producing cells to the lung as a result of increased concentrations of the chemokines CXCL9, 10, and 11, which recruit cells to sites of inflammation

Page 110: M. Tuberculosis and immune responses

IL 23

• Essential for the IL-17 response during TB• Dispensable for protection and antigen-

specific IFN-γ responses if IL-12p70 is available

Page 111: M. Tuberculosis and immune responses

The double-edged sword of suppressivecytokines in tuberculosis

• IL10

• TH2 cytokine

• Type1 IFN

Page 112: M. Tuberculosis and immune responses

IL10• An immunosuppressive cytokine induced by TB

for immune evasion • If overproduced, IL-10 can contribute to

chronic infection

• IL-10 was elevated in the lungs , BAL fluid , sputum and serum of active TB patients

Page 113: M. Tuberculosis and immune responses

• Activation of TLR4 (but not of TLR2) will induce higher levels of IL-10 production by MQ

• Bone marrow–derived Neu infected in vitro or Neu isolated from the lungs of mice challenged with TB produce significant levels of IL-10

Page 114: M. Tuberculosis and immune responses

Th2 Cytokines

• Chronic worm infection of mice reduces immunogenicity to M.TB and reduce Th1 responses.

• Generally ,Helminthes reduce protective immune responses to M.TB infection.

Page 115: M. Tuberculosis and immune responses

Type I IFNs

• The type I IFN family of cytokines have pleiotropic effects on the broader immune response

• Role :1. Increases susceptibility to M.TB 2. Suppresses production of host-protective

cytokines including IL-1 and IL-12 following M.TB infection in MQ

3. Induction of the immunosuppressive cytokine IL-10

Page 116: M. Tuberculosis and immune responses

Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB

• Experimental models• Immune response against TB

- Innate immune defense- Adaptive immune defense

• HIV and TB• Difficulties and advantages in TB research• Risk factors

Page 117: M. Tuberculosis and immune responses

HIV and TB :

• TB is the most common opportunistic infection worldwide in HIV-1-infected persons

• Antiretroviral therapy (ART) for HIV-1 infection improves immune resistance to TB

• Vitamin D reportedly inhibits HIV-1 and TB infection in MQ through the induction of autophagy.

Page 118: M. Tuberculosis and immune responses
Page 119: M. Tuberculosis and immune responses

TB-IRIS

• HIV+ patient ---> immunosuppressed--->ART----> decreased viral load and increased CD4+ T cells ---> sudden over activation of immune system ----> rapid recognition of pathogens in body (like TB ) ----> causes severe systemic inflammatory disease

Page 120: M. Tuberculosis and immune responses

Outline :• M TB history• M TB epidemiology• M TB bacteriology• TB clinical feature - symptoms - transmission - active vs. latent TB

• Experimental models• Immune response against TB

- Innate immune defense- Adaptive immune defense

• HIV and TB• Difficulties and advantages in TB research• Risk factors

Page 121: M. Tuberculosis and immune responses
Page 122: M. Tuberculosis and immune responses

Outline :• M TB history• M TB epidemiology• M TB bacteriology• TB clinical feature - symptoms - transmission - active vs. latent TB

• Experimental models• Immune response against TB

- Innate immune defense- Adaptive immune defense

• HIV and TB• Difficulties and advantages in studying• Risk factors

Page 123: M. Tuberculosis and immune responses
Page 124: M. Tuberculosis and immune responses
Page 125: M. Tuberculosis and immune responses
Page 126: M. Tuberculosis and immune responses
Page 127: M. Tuberculosis and immune responses
Page 128: M. Tuberculosis and immune responses
Page 129: M. Tuberculosis and immune responses
Page 130: M. Tuberculosis and immune responses
Page 131: M. Tuberculosis and immune responses
Page 132: M. Tuberculosis and immune responses
Page 133: M. Tuberculosis and immune responses
Page 134: M. Tuberculosis and immune responses
Page 135: M. Tuberculosis and immune responses
Page 136: M. Tuberculosis and immune responses

Reference :

Page 137: M. Tuberculosis and immune responses

Thanks for your

attention